filmov
tv
EMPA-KIDNEY: Introduction to the trial
Показать описание
Oxford Population Health
Рекомендации по теме
0:02:33
EMPA-KIDNEY: Introduction to the trial
0:03:21
EMPA CKD - 3 min trial summary
0:57:22
Emerging data from EMPA-KIDNEY study
0:01:52
EMPA-KIDNEY results: Empagliflozin reduces kidney disease progression and cardiovascular deaths
0:01:35
EMPA-KIDNEY: meta-analysis results
1:08:25
Webinar: Overview of high impact clinical trials: EMPA-Kidney and STOP-ACEi
0:03:07
EMPA KIDNEY FINAL
0:10:10
EMPA-Kidney Results
0:05:38
ESC TV On the Road - #AHA22 - DCP and EMPA-KIDNEY trials
0:07:23
Empa Kidney Trial
0:05:15
EMPA-KIDNEY
0:38:48
Radcliffe & CardioNerds @AHA22: EMPA-Kidney: Empagliflozin & CV Outcomes in Patients with CK...
1:06:22
EMPA KIDNEY results: Flozins for all CKD with Dr Will Herrington
0:08:58
EMPA-KIDNEY
0:09:06
SGLT2 Inhibitors in Chronic Kidney Disease
0:02:09
Understanding kidney disease
0:03:14
STOP ACEi Trial: Everything you need to know in 3minutes
1:35:59
Prevent progression of chronic kidney disease
0:28:56
Christine Limonte, MD - Update on SGLT2i: Real-world Use and Special Population
0:02:53
DAPA CKD Trial
0:56:43
Renal events in patients receiving Neprilysin inhibitors: a systematic review and meta-analysis
1:24:14
Empagliflozin & Kidney Disease: The EMPA-KIDNEY STUDY (LIVE)
0:27:44
KDIGO Summit on Diabetes in CKD Plenary: Learnings from Mega-Trials on Glycemic Control and Outcomes
0:03:02
Results of the CREDENCE kidney disease trial - standalone grabs with Professor Vlado Perkovic
join shbcf.ru
0:02:33
0:03:21
0:57:22
0:01:52
0:01:35
1:08:25
0:03:07
0:10:10
0:05:38
0:07:23
0:05:15
0:38:48
1:06:22
0:08:58
0:09:06
0:02:09
0:03:14
1:35:59
0:28:56
0:02:53
0:56:43
1:24:14
0:27:44
0:03:02